Clinical relevance of plasma endostatin levels in patients with acute myeloid leukemia or myelodysplastic syndrome.

被引：0
|
作者：
Lai, R [1 ]
Estey, E [1 ]
Yu, S [1 ]
Kantarjian, H [1 ]
Gidel, C [1 ]
Beran, M [1 ]
Manshouri, T [1 ]
Quackenbush, R [1 ]
Keating, M [1 ]
Albitar, M [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
455
引用
收藏
页码：106A / 106A
页数：1
相关论文
共 50 条
  • [1] Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome
    Lai, B
    Estey, E
    Shen, Y
    Despa, S
    Kantarjian, H
    Beran, M
    Maushori, T
    Quackenbuch, RC
    Keating, M
    Albitar, M
    CANCER, 2002, 94 (01) : 14 - 17
  • [2] Significance of angiogenin plasma concentrations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Verstovsek, S
    Kantarjian, H
    Aguayo, A
    Manshouri, T
    Freireich, E
    Keating, M
    Estey, E
    Albitar, M
    BLOOD, 2000, 96 (11) : 103A - 103A
  • [3] Plasma hepatocyte growth factor is prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
    Verstovsek, S
    Kantarjian, H
    Estey, E
    Aguayo, A
    Giles, FJ
    Manshouri, T
    Koller, C
    Estrov, Z
    Freireich, E
    Keating, M
    Albitar, M
    BLOOD, 2000, 96 (11) : 104A - 104A
  • [4] Correlation of new method for measuring plasma myeloperoxidase with clinical behavior in acute myeloid leukemia and myelodysplastic syndrome.
    Abdool, Adam
    Wang, Xiugiang
    Jilani, Iman
    Zhou, Weidong
    Kantargian, Hagop
    Estey, Elihu
    Giles, Francis
    Albitar, Maher
    BLOOD, 2007, 110 (11) : 148B - 148B
  • [5] Molecular and clinical predictors of venous thromboembolism in acute myeloid leukemia and myelodysplastic syndrome.
    Banaszak, Lauren Gabriele
    Hassan, Ayesha
    Stepanovic, Adam
    Cabral, Paloma
    Lasarev, Michael
    Reinig, Erica
    Mattison, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19008 - E19008
  • [6] Clinical significance of free circulating CD34 in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Hodge, Menna
    Giles, Francis
    Abdool, Adam
    O'Brien, Susan
    Keating, Michael
    Jilani, Iman
    Estrov, Zeev
    Estey, Elihu
    Kantadian, Hagop
    Albitar, Maher
    BLOOD, 2006, 108 (11) : 203B - 203B
  • [7] STUDY OF PLASMA ENDOSTATIN LEVEL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Haggag, R.
    Hussein, O.
    El Moaty, H. Abd
    Omran, A.
    Ebian, H.
    HAEMATOLOGICA, 2015, 100 : 369 - 369
  • [8] The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome
    Hock, BD
    McKenzie, JL
    Patton, WN
    Haring, LF
    Yang, Y
    Shen, Y
    Estey, EH
    Albitar, M
    CANCER, 2003, 98 (08) : 1681 - 1688
  • [9] Clinical relevance of circulating myeloperoxidase (MPO) in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Jilani, I
    Vincenti, T
    Faraji, H
    Giles, FJ
    Estey, E
    Kantarjian, HM
    Albitar, M
    BLOOD, 2004, 104 (11) : 305A - 305A
  • [10] High levels of soluble HLA-I in patients with acute myeloid leukemia and myelodysplastic syndrome: Relevance to clinical behavior and b2M levels
    Albitar, M
    Johnson, M
    Do, KA
    Day, A
    Jilani, I
    Pierce, S
    Estey, E
    Kantarjian, H
    Keating, M
    Verstovsek, S
    O'Brien, S
    Giles, FJ
    BLOOD, 2004, 104 (11) : 304A - 304A
12345